跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BICART SELECT COMBI-PAK - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BICART SELECT COMBI-PAK
Authorized
STANDARD
BICART SELECT COMBI-PAK
Vantive ULC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
dafdd01390a2c2bd
Company
Vantive ULC
Type
Standard
Approval Details
Approval Id
dafdd01390a2c2bd
Drug Approval Canada Name
BICART SELECT COMBI-PAK
Product Name
BICART SELECT COMBI-PAK
Status
Marketed
Status Date
2024-05-08
Original Market Date
2016-02-22
Din
02425246
Drug Class
Human
Dosage Form
Kit , Powder For Solution
Route Of Administration
Haemodialysis
Schedule
Ethical
Ahfs
40:34.00*
Atc Original
B05ZA HEMODIALYTICS, CONCENTRATES
Atc Name
b 05 za
Aig Number
0216887013
Company Name
Vantive ULC
Company Address
6675 Millcreek Drive, Unit 2, Mississauga, Ontario, Canada, L5N 5M4
Active Ingredients
SODIUM BICARBONATE
720 G / CARTRIDGE
SODIUM CHLORIDE
1200 G / CARTRIDGE
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
dafdd01390a2c2bd
Type
Standard
Back to Health Canada Approvals